Tags: Drug.

Repaglinide is an antidiabetic drug in the class of medications known as meglitinides and was invented in 1983. It is sold by Novo Nordisk under the name of Prandin in the U.S. GlucoNorm in Canada Surepost in Japan Repaglinide in Egypt by EIPICO and NovoNorm elsewhere. In Japan it is produced by Dainippon Sumitomo Pharma.

Repaglinide.svg
ATC prefix
A10
ATC suffix
BX02
Bioavailability
56.0
CAS number
135062-02-1
DrugBank
DB00912
FDA UNII code
668Z8C33LU
IUPAC name
(S)-(+)-2-ethoxy-4-[2-(3-methyl-1-[2-(piperidin-1-yl)phenyl]butylamino)-2-oxoethyl]benzoic acid
PubChem
65981

Loading...

This page contains content from the copyrighted Wikipedia article "Repaglinide"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.